Zdrowie i gospodarka · 02/04/2009
FDA Releases Draft Guidance for Somatic Cell Therapy in Cardiac Disease
The FDA has made available a draft document outlining recommendations for sponsors of somatic cell therapies treating cardiac disease, covering study design, product delivery systems, and IND submissions.
Source: Federal Register — Food and Drug AdministrationOpen original release →